| Literature DB >> 20573400 |
Letizia Mattii1, Barbara Battolla, Antonio Azzarà, Giuseppina D'Urso, Umberto Montali, Mario Petrini.
Abstract
Glycosylation of cytokines appears to be responsible for several differences in their activity, and focusing on G-CSF, several divergences between the non-glycosylated G-CSF, Filgrastim, and the glycosylated G-CSF, Lenograstim, have been reported. To verify the role of G-CSF glycosylation in mediating these differences we tested in vitro the effects on the RhoA activation of the different G-CSFs, including deglycosylated Lenograstim. The results showed that Filgrastim induced sustained-RhoA activation while Lenograstim did not do so. Deglycosylated Lenograstim mimicked Filgrastim, resulting in RhoA hyper-activation. These in vitro findings demonstrate that the glycosylation of G-CSF plays a crucial role in RhoA activation.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20573400 DOI: 10.1016/j.leukres.2010.05.027
Source DB: PubMed Journal: Leuk Res ISSN: 0145-2126 Impact factor: 3.156